Treatment of recurrent glioblastoma with stereotactic radiotherapy: Long-term results of a mono-institutional trial

Tumori

Volumn 97, Issue 1, 2011, Pages 56-61

  Maranzano, Ernesto ^a   Anselmo, Paola ^a   Casale, Michelina ^a   Trippa, Fabio ^a   Carletti, Sandro ^a   Principi, Massimo ^a   Loreti, Fabio ^a   Italiani, Marco ^a   Caserta, Claudia ^a   Giorgi, Cesare ^a  

^a S MARIA HOSPITAL   (Italy)

Author keywords

Fractionated stereotactic radiotherapy; Glioblastoma multiforme; Radiosurgery; Re irradiation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; LONGITUDINAL STUDY; MALE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; SEX RATIO; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953871710     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/611.7139     Document Type: Article

References (27)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352: 987-996, 2005. (Pubitemid 40349501)
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol, 10: 459-466, 2009.
3. Combs SE, Gutwein S, Thilmann Ch, Huber P, Debus J, Schulz-Ertner D: Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol, 74: 167-171, 2005. (Pubitemid 41478913)
4. Combs SE, Ahmadi R, Schulz-Ertner D, Thilmann C, Debus J: Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation. J Neurooncol, 71: 319-323, 2005. (Pubitemid 40372964)
5. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys, 16: 1405-1409, 1989. (Pubitemid 19154322)
6. Dirks P, Bernstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg, 36: 271-275, 1993. (Pubitemid 23248140)
7. Harsh GR 4th, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery, 21: 615-621, 1987. (Pubitemid 18001497)
8. Brandes AA, Fiorentino MV: The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest, 14: 551-559, 1996. (Pubitemid 26423517)
9. Brandes AA, Ermani M, Turazzi S, Scelzi E, Berti F, Amistà P, Rotilio A, Licata C, Fiorentino MV: Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study. J Clin Oncol, 17: 645-650, 1999. (Pubitemid 29075253)
10. Fabi A, Metro G, Russillo M, Vidiri A, Carapella CM, Maschio M, Cognetti F, Jandolo B, Mirri MA, Sperduti I, Telera S, Carosi M, Pace A: Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation. BMC Cancer, 9: 101, 2009.
11. Shrieve DC, Tarbell NJ, Alexander E 3rd, Kooy HM, Black PM, Dunbar S, Loeffler JS, Stereotactic radiotherapy: a technique for dose optimization and escalation for intracranial tumors. Acta Neurochir Suppl, 62: 118-123, 1994.
12. Mehta MP, Masciopinto J, Rozental J, Levin A, Chappell R, Bastin K, Miles J, Turski P, Kubsad S, Mackie T: Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys, 30: 541-549, 1994. (Pubitemid 24304464)
13. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys, 47: 291-298, 2000. (Pubitemid 30236367)
14. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D: Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol, 23: 8863-8869, 2005. (Pubitemid 46211533)
15. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB: Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys, 45: 1133-1141, 1999.
16. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M, Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol, 13: 1642-1648, 1995.
17. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz- Ertner D: Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer, 104: 2168-2173, 2005.
18. Combs SE, Debus J, Schulz-Ertner D: Radiotherapeutic alternatives for previously irradiated recurrent gliomas. BMC Cancer, 7: 167, 2007.
19. Veninga T, Langendijk HA, Slotman BJ, Rutten EH, van der Kogel AJ, Prick MJ, Keyser A, van der Maazen RW: Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol, 59: 127-137, 2001.
20. Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, Gutin PH, Larson DA: Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys, 36: 433-441, 1996.
21. Ang KK, Price RE, Stephens LC, Jiang GL, Feng Y, Schultheiss TE, Peters LJ: The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys, 25: 459-464, 1993.
22. Van der Kogel AJ: Clinical implications of radiobiological studies on CNS tolerance. In: Glioma: Principles and Practice in Neuro-Oncology, Karim A, Laws E (Eds), pp 179-188, Springer-Verlag, Heidelberg, 1991.
23. Mayer R, Sminia P: Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys, 70: 1350-1360, 2008.
24. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF: Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst, 85: 704-710, 1993.
25. Dritschilo A, Bruckman JE, Cassady JR, Belli JA: Tolerance of brain to multiple courses of radiation therapy. Clinical experiences. Br J Radiol, 54: 782-786, 1981.
26. Horns J, Webber MM: Retreatment of brain tumors. Radiology, 88: 322-325, 1967.
27. Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ Jr: A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys, 43: 293-298, 1999.